Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal Allopurinol for Fetal Hypoxia
NCT00189007Phase 3Unknown
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fetal hypoxia comparing Allopurinol with Placebo (2 arms). Primary endpoint: Free radical production and markers of neuronal damage at 24 hours. Status: unknown.
02
Drugs
allopurinol
03
Conditions
fetal hypoxia
Beyond the preview
Go deeper on NCT00189007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189007.